Cryopreservation Media Comprehensive Study by Type (Lysogenic broth, Protein-free media, Specialty media, Serum-free media, Chemically-defined media), Application (Biobanks, Gene Banks, Hospitals, Tissue engineering, Stem cell technologies, Therapeutic Applications, Cancer and Research Applications, Clinical Trials, Others), Bio-specimens Types (Human Tissue Samples, Stem Cells, Organs, Others) Players and Region - Global Market Outlook to 2028

Cryopreservation Media Market by XX Submarkets | Forecast Years 2023-2028  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Cryopreservation Media
Cryopreservation Media is designed to maintain and preserve cells at low environmental temperature and decreases the risk of infection by microbes and other cell types. It provides a safe environment for cells and tissues while undergoing freezing, storage and thawing process. This is specially framed media which contains a defined serum substitute as well as an improved concentration of a cryopreservative that increases the recovery and viability of healthy cells compared to conventional freezing media.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


Cryopreservation Media is a fragmented market due to the presence of several regional and international players. The players are focusing on planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Cryopreservation Media market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Thermo Fisher Scientific, Inc. (United States), Osiris Therapeutics, Inc (United States), Sigma-Aldrich Corporation (United States), VWR Corporation (United States), Biolife Solutions, Inc. (United States), Lifeline Scientific, Inc. (United States), Cesca Therapeutics, Inc. (United States), BioCision, LLC (United States), Core Dynamics, Ltd. (Israel), Custom Biogenic Systems, Inc. (United States), So-Low Environmental Equipment Co., Inc. (United States) and Princeton Cryotech, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are So-Low Environmental Equipment Co., Inc. (United States) and Princeton Cryotech, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Cryopreservation Media market by Type (Lysogenic broth, Protein-free media, Specialty media, Serum-free media and Chemically-defined media), Application (Biobanks, Gene Banks, Hospitals, Tissue engineering, Stem cell technologies, Therapeutic Applications, Cancer and Research Applications, Clinical Trials and Others) and Region.



On the basis of geography, the market of Cryopreservation Media has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Bio-specimens Types, the sub-segment i.e. Human Tissue Samples will boost the Cryopreservation Media market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Adoption in Conserving Cord Blood Stem Cells of Newborns and The increasing Trend of Cryopreservation of Eggs and Embryos

Market Growth Drivers:
Increasing Healthcare Expenditure, Increasing R&D Investments, Advancement in Biobanking and Advances in Regenerative Medicine

Challenges:
Lack of Consumer Awareness Regarding Cryopreservation Media

Restraints:
High Cost of Advanced Techniques and Stability Issues, Tissue Injury During Freezing & Thawing

Opportunities:
Increasing Awareness for Cryopreservation Media in Emerging Countries

Market Leaders and their expansionary development strategies
In August 2023, Thermo Fischer Scientific completed acquisition of CorEvitas. a leading provider of regulatory-grade, real-world evidence for approved medical treatments and therapies, from Audax Private Equity (“Audax”), for USD 912.5 million in cash.
In August 2023, Thermo Fischer Scientific recognized by R&D 100 Awards for innovation in science and technology, honoring the top 100 revolutionary products in science and technology from around the world, for three unique innovations that aid researchers’ and scientists’ work in a variety of life science applications, including bioproduction and small-molecule analysis.


Key Target Audience
Cryopreservation centers, Health care centers, Hospitals, Pharmaceutical labs, Cancer and Research centers and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Lysogenic broth
  • Protein-free media
  • Specialty media
  • Serum-free media
  • Chemically-defined media
By Application
  • Biobanks
  • Gene Banks
  • Hospitals
  • Tissue engineering
  • Stem cell technologies
  • Therapeutic Applications
  • Cancer and Research Applications
  • Clinical Trials
  • Others
By Bio-specimens Types
  • Human Tissue Samples
  • Stem Cells
  • Organs
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Healthcare Expenditure
      • 3.2.2. Increasing R&D Investments
      • 3.2.3. Advancement in Biobanking
      • 3.2.4. Advances in Regenerative Medicine
    • 3.3. Market Challenges
      • 3.3.1. Lack of Consumer Awareness Regarding Cryopreservation Media
    • 3.4. Market Trends
      • 3.4.1. Adoption in Conserving Cord Blood Stem Cells of Newborns
      • 3.4.2. The increasing Trend of Cryopreservation of Eggs and Embryos
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
  • 5. Global Cryopreservation Media, by Type, Application, Bio-specimens Types and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Cryopreservation Media (Volume)
      • 5.2.1. Global Cryopreservation Media by: Type (Volume)
        • 5.2.1.1. Lysogenic broth
        • 5.2.1.2. Protein-free media
        • 5.2.1.3. Specialty media
        • 5.2.1.4. Serum-free media
        • 5.2.1.5. Chemically-defined media
      • 5.2.2. Global Cryopreservation Media by: Application (Volume)
        • 5.2.2.1. Biobanks
        • 5.2.2.2. Gene Banks
        • 5.2.2.3. Hospitals
        • 5.2.2.4. Tissue engineering
        • 5.2.2.5. Stem cell technologies
        • 5.2.2.6. Therapeutic Applications
        • 5.2.2.7. Cancer and Research Applications
        • 5.2.2.8. Clinical Trials
        • 5.2.2.9. Others
      • 5.2.3. Global Cryopreservation Media by: Bio-specimens Types (Volume)
        • 5.2.3.1. Human Tissue Samples
        • 5.2.3.2. Stem Cells
        • 5.2.3.3. Organs
        • 5.2.3.4. Others
      • 5.2.4. Global Cryopreservation Media Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Cryopreservation Media (Price)
      • 5.3.1. Global Cryopreservation Media by: Type (Price)
  • 6. Cryopreservation Media: Manufacturers/Players Analysis
    • 6.1. Company Profile
      • 6.1.1. Thermo Fisher Scientific, Inc. (United States)
        • 6.1.1.1. Business Overview
        • 6.1.1.2. Products/Services Offerings
        • 6.1.1.3. Financial Analysis
        • 6.1.1.4. SWOT Analysis
      • 6.1.2. Osiris Therapeutics, Inc (United States)
        • 6.1.2.1. Business Overview
        • 6.1.2.2. Products/Services Offerings
        • 6.1.2.3. Financial Analysis
        • 6.1.2.4. SWOT Analysis
      • 6.1.3. Sigma-Aldrich Corporation (United States)
        • 6.1.3.1. Business Overview
        • 6.1.3.2. Products/Services Offerings
        • 6.1.3.3. Financial Analysis
        • 6.1.3.4. SWOT Analysis
      • 6.1.4. VWR Corporation (United States)
        • 6.1.4.1. Business Overview
        • 6.1.4.2. Products/Services Offerings
        • 6.1.4.3. Financial Analysis
        • 6.1.4.4. SWOT Analysis
      • 6.1.5. Biolife Solutions, Inc. (United States)
        • 6.1.5.1. Business Overview
        • 6.1.5.2. Products/Services Offerings
        • 6.1.5.3. Financial Analysis
        • 6.1.5.4. SWOT Analysis
      • 6.1.6. Lifeline Scientific, Inc. (United States)
        • 6.1.6.1. Business Overview
        • 6.1.6.2. Products/Services Offerings
        • 6.1.6.3. Financial Analysis
        • 6.1.6.4. SWOT Analysis
      • 6.1.7. Cesca Therapeutics, Inc. (United States)
        • 6.1.7.1. Business Overview
        • 6.1.7.2. Products/Services Offerings
        • 6.1.7.3. Financial Analysis
        • 6.1.7.4. SWOT Analysis
      • 6.1.8. BioCision, LLC (United States)
        • 6.1.8.1. Business Overview
        • 6.1.8.2. Products/Services Offerings
        • 6.1.8.3. Financial Analysis
        • 6.1.8.4. SWOT Analysis
      • 6.1.9. Core Dynamics, Ltd. (Israel)
        • 6.1.9.1. Business Overview
        • 6.1.9.2. Products/Services Offerings
        • 6.1.9.3. Financial Analysis
        • 6.1.9.4. SWOT Analysis
      • 6.1.10. Custom Biogenic Systems, Inc. (United States)
        • 6.1.10.1. Business Overview
        • 6.1.10.2. Products/Services Offerings
        • 6.1.10.3. Financial Analysis
        • 6.1.10.4. SWOT Analysis
      • 6.1.11. So-Low Environmental Equipment Co., Inc. (United States)
        • 6.1.11.1. Business Overview
        • 6.1.11.2. Products/Services Offerings
        • 6.1.11.3. Financial Analysis
        • 6.1.11.4. SWOT Analysis
      • 6.1.12. Princeton Cryotech, Inc. (United States)
        • 6.1.12.1. Business Overview
        • 6.1.12.2. Products/Services Offerings
        • 6.1.12.3. Financial Analysis
        • 6.1.12.4. SWOT Analysis
  • 7. Global Cryopreservation Media Sale, by Type, Application, Bio-specimens Types and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Cryopreservation Media (Volume)
      • 7.2.1. Global Cryopreservation Media by: Type (Volume)
        • 7.2.1.1. Lysogenic broth
        • 7.2.1.2. Protein-free media
        • 7.2.1.3. Specialty media
        • 7.2.1.4. Serum-free media
        • 7.2.1.5. Chemically-defined media
      • 7.2.2. Global Cryopreservation Media by: Application (Volume)
        • 7.2.2.1. Biobanks
        • 7.2.2.2. Gene Banks
        • 7.2.2.3. Hospitals
        • 7.2.2.4. Tissue engineering
        • 7.2.2.5. Stem cell technologies
        • 7.2.2.6. Therapeutic Applications
        • 7.2.2.7. Cancer and Research Applications
        • 7.2.2.8. Clinical Trials
        • 7.2.2.9. Others
      • 7.2.3. Global Cryopreservation Media by: Bio-specimens Types (Volume)
        • 7.2.3.1. Human Tissue Samples
        • 7.2.3.2. Stem Cells
        • 7.2.3.3. Organs
        • 7.2.3.4. Others
      • 7.2.4. Global Cryopreservation Media Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Cryopreservation Media (Price)
      • 7.3.1. Global Cryopreservation Media by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Cryopreservation Media Sales: by Type(Unit)
  • Table 2. Cryopreservation Media Sales Lysogenic broth , by Region Unit (2017-2022)
  • Table 3. Cryopreservation Media Sales Protein-free media , by Region Unit (2017-2022)
  • Table 4. Cryopreservation Media Sales Specialty media , by Region Unit (2017-2022)
  • Table 5. Cryopreservation Media Sales Serum-free media , by Region Unit (2017-2022)
  • Table 6. Cryopreservation Media Sales Chemically-defined media , by Region Unit (2017-2022)
  • Table 7. Cryopreservation Media Sales: by Application(Unit)
  • Table 8. Cryopreservation Media Sales Biobanks , by Region Unit (2017-2022)
  • Table 9. Cryopreservation Media Sales Gene Banks , by Region Unit (2017-2022)
  • Table 10. Cryopreservation Media Sales Hospitals , by Region Unit (2017-2022)
  • Table 11. Cryopreservation Media Sales Tissue engineering , by Region Unit (2017-2022)
  • Table 12. Cryopreservation Media Sales Stem cell technologies , by Region Unit (2017-2022)
  • Table 13. Cryopreservation Media Sales Therapeutic Applications , by Region Unit (2017-2022)
  • Table 14. Cryopreservation Media Sales Cancer and Research Applications , by Region Unit (2017-2022)
  • Table 15. Cryopreservation Media Sales Clinical Trials , by Region Unit (2017-2022)
  • Table 16. Cryopreservation Media Sales Others , by Region Unit (2017-2022)
  • Table 17. Cryopreservation Media Sales: by Bio-specimens Types(Unit)
  • Table 18. Cryopreservation Media Sales Human Tissue Samples , by Region Unit (2017-2022)
  • Table 19. Cryopreservation Media Sales Stem Cells , by Region Unit (2017-2022)
  • Table 20. Cryopreservation Media Sales Organs , by Region Unit (2017-2022)
  • Table 21. Cryopreservation Media Sales Others , by Region Unit (2017-2022)
  • Table 22. South America Cryopreservation Media Sales, by Country Unit (2017-2022)
  • Table 23. South America Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 24. South America Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 25. South America Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 26. Brazil Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 27. Brazil Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 28. Brazil Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 29. Argentina Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 30. Argentina Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 31. Argentina Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 32. Rest of South America Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 33. Rest of South America Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 34. Rest of South America Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 35. Asia Pacific Cryopreservation Media Sales, by Country Unit (2017-2022)
  • Table 36. Asia Pacific Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 37. Asia Pacific Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 38. Asia Pacific Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 39. China Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 40. China Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 41. China Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 42. Japan Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 43. Japan Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 44. Japan Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 45. India Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 46. India Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 47. India Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 48. South Korea Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 49. South Korea Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 50. South Korea Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 51. Taiwan Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 52. Taiwan Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 53. Taiwan Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 54. Australia Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 55. Australia Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 56. Australia Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 57. Rest of Asia-Pacific Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 58. Rest of Asia-Pacific Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 59. Rest of Asia-Pacific Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 60. Europe Cryopreservation Media Sales, by Country Unit (2017-2022)
  • Table 61. Europe Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 62. Europe Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 63. Europe Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 64. Germany Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 65. Germany Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 66. Germany Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 67. France Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 68. France Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 69. France Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 70. Italy Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 71. Italy Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 72. Italy Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 73. United Kingdom Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 74. United Kingdom Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 75. United Kingdom Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 76. Netherlands Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 77. Netherlands Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 78. Netherlands Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 79. Rest of Europe Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 80. Rest of Europe Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 81. Rest of Europe Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 82. MEA Cryopreservation Media Sales, by Country Unit (2017-2022)
  • Table 83. MEA Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 84. MEA Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 85. MEA Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 86. Middle East Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 87. Middle East Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 88. Middle East Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 89. Africa Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 90. Africa Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 91. Africa Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 92. North America Cryopreservation Media Sales, by Country Unit (2017-2022)
  • Table 93. North America Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 94. North America Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 95. North America Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 96. United States Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 97. United States Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 98. United States Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 99. Canada Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 100. Canada Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 101. Canada Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 102. Mexico Cryopreservation Media Sales, by Type Unit (2017-2022)
  • Table 103. Mexico Cryopreservation Media Sales, by Application Unit (2017-2022)
  • Table 104. Mexico Cryopreservation Media Sales, by Bio-specimens Types Unit (2017-2022)
  • Table 105. Cryopreservation Media: by Type(USD/Units)
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Company Basic Information, Sales Area and Its Competitors
  • Table 115. Company Basic Information, Sales Area and Its Competitors
  • Table 116. Company Basic Information, Sales Area and Its Competitors
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Cryopreservation Media Sales: by Type(Unit)
  • Table 119. Cryopreservation Media Sales Lysogenic broth , by Region Unit (2023-2028)
  • Table 120. Cryopreservation Media Sales Protein-free media , by Region Unit (2023-2028)
  • Table 121. Cryopreservation Media Sales Specialty media , by Region Unit (2023-2028)
  • Table 122. Cryopreservation Media Sales Serum-free media , by Region Unit (2023-2028)
  • Table 123. Cryopreservation Media Sales Chemically-defined media , by Region Unit (2023-2028)
  • Table 124. Cryopreservation Media Sales: by Application(Unit)
  • Table 125. Cryopreservation Media Sales Biobanks , by Region Unit (2023-2028)
  • Table 126. Cryopreservation Media Sales Gene Banks , by Region Unit (2023-2028)
  • Table 127. Cryopreservation Media Sales Hospitals , by Region Unit (2023-2028)
  • Table 128. Cryopreservation Media Sales Tissue engineering , by Region Unit (2023-2028)
  • Table 129. Cryopreservation Media Sales Stem cell technologies , by Region Unit (2023-2028)
  • Table 130. Cryopreservation Media Sales Therapeutic Applications , by Region Unit (2023-2028)
  • Table 131. Cryopreservation Media Sales Cancer and Research Applications , by Region Unit (2023-2028)
  • Table 132. Cryopreservation Media Sales Clinical Trials , by Region Unit (2023-2028)
  • Table 133. Cryopreservation Media Sales Others , by Region Unit (2023-2028)
  • Table 134. Cryopreservation Media Sales: by Bio-specimens Types(Unit)
  • Table 135. Cryopreservation Media Sales Human Tissue Samples , by Region Unit (2023-2028)
  • Table 136. Cryopreservation Media Sales Stem Cells , by Region Unit (2023-2028)
  • Table 137. Cryopreservation Media Sales Organs , by Region Unit (2023-2028)
  • Table 138. Cryopreservation Media Sales Others , by Region Unit (2023-2028)
  • Table 139. South America Cryopreservation Media Sales, by Country Unit (2023-2028)
  • Table 140. South America Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 141. South America Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 142. South America Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 143. Brazil Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 144. Brazil Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 145. Brazil Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 146. Argentina Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 147. Argentina Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 148. Argentina Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 149. Rest of South America Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 150. Rest of South America Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 151. Rest of South America Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 152. Asia Pacific Cryopreservation Media Sales, by Country Unit (2023-2028)
  • Table 153. Asia Pacific Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 154. Asia Pacific Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 155. Asia Pacific Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 156. China Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 157. China Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 158. China Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 159. Japan Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 160. Japan Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 161. Japan Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 162. India Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 163. India Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 164. India Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 165. South Korea Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 166. South Korea Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 167. South Korea Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 168. Taiwan Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 169. Taiwan Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 170. Taiwan Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 171. Australia Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 172. Australia Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 173. Australia Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 174. Rest of Asia-Pacific Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 175. Rest of Asia-Pacific Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 176. Rest of Asia-Pacific Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 177. Europe Cryopreservation Media Sales, by Country Unit (2023-2028)
  • Table 178. Europe Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 179. Europe Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 180. Europe Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 181. Germany Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 182. Germany Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 183. Germany Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 184. France Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 185. France Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 186. France Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 187. Italy Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 188. Italy Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 189. Italy Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 190. United Kingdom Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 191. United Kingdom Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 192. United Kingdom Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 193. Netherlands Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 194. Netherlands Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 195. Netherlands Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 196. Rest of Europe Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 197. Rest of Europe Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 198. Rest of Europe Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 199. MEA Cryopreservation Media Sales, by Country Unit (2023-2028)
  • Table 200. MEA Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 201. MEA Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 202. MEA Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 203. Middle East Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 204. Middle East Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 205. Middle East Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 206. Africa Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 207. Africa Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 208. Africa Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 209. North America Cryopreservation Media Sales, by Country Unit (2023-2028)
  • Table 210. North America Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 211. North America Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 212. North America Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 213. United States Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 214. United States Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 215. United States Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 216. Canada Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 217. Canada Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 218. Canada Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 219. Mexico Cryopreservation Media Sales, by Type Unit (2023-2028)
  • Table 220. Mexico Cryopreservation Media Sales, by Application Unit (2023-2028)
  • Table 221. Mexico Cryopreservation Media Sales, by Bio-specimens Types Unit (2023-2028)
  • Table 222. Cryopreservation Media: by Type(USD/Units)
  • Table 223. Research Programs/Design for This Report
  • Table 224. Key Data Information from Secondary Sources
  • Table 225. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Cryopreservation Media: by Type Unit (2017-2022)
  • Figure 5. Global Cryopreservation Media: by Application Unit (2017-2022)
  • Figure 6. Global Cryopreservation Media: by Bio-specimens Types Unit (2017-2022)
  • Figure 7. South America Cryopreservation Media Share (%), by Country
  • Figure 8. Asia Pacific Cryopreservation Media Share (%), by Country
  • Figure 9. Europe Cryopreservation Media Share (%), by Country
  • Figure 10. MEA Cryopreservation Media Share (%), by Country
  • Figure 11. North America Cryopreservation Media Share (%), by Country
  • Figure 12. Global Cryopreservation Media: by Type USD/Units (2017-2022)
  • Figure 13. Thermo Fisher Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 14. Thermo Fisher Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 15. Osiris Therapeutics, Inc (United States) Revenue, Net Income and Gross profit
  • Figure 16. Osiris Therapeutics, Inc (United States) Revenue: by Geography 2022
  • Figure 17. Sigma-Aldrich Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sigma-Aldrich Corporation (United States) Revenue: by Geography 2022
  • Figure 19. VWR Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. VWR Corporation (United States) Revenue: by Geography 2022
  • Figure 21. Biolife Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Biolife Solutions, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Lifeline Scientific, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Lifeline Scientific, Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Cesca Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Cesca Therapeutics, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. BioCision, LLC (United States) Revenue, Net Income and Gross profit
  • Figure 28. BioCision, LLC (United States) Revenue: by Geography 2022
  • Figure 29. Core Dynamics, Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 30. Core Dynamics, Ltd. (Israel) Revenue: by Geography 2022
  • Figure 31. Custom Biogenic Systems, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 32. Custom Biogenic Systems, Inc. (United States) Revenue: by Geography 2022
  • Figure 33. So-Low Environmental Equipment Co., Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 34. So-Low Environmental Equipment Co., Inc. (United States) Revenue: by Geography 2022
  • Figure 35. Princeton Cryotech, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. Princeton Cryotech, Inc. (United States) Revenue: by Geography 2022
  • Figure 37. Global Cryopreservation Media: by Type Unit (2023-2028)
  • Figure 38. Global Cryopreservation Media: by Application Unit (2023-2028)
  • Figure 39. Global Cryopreservation Media: by Bio-specimens Types Unit (2023-2028)
  • Figure 40. South America Cryopreservation Media Share (%), by Country
  • Figure 41. Asia Pacific Cryopreservation Media Share (%), by Country
  • Figure 42. Europe Cryopreservation Media Share (%), by Country
  • Figure 43. MEA Cryopreservation Media Share (%), by Country
  • Figure 44. North America Cryopreservation Media Share (%), by Country
  • Figure 45. Global Cryopreservation Media: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Thermo Fisher Scientific, Inc. (United States)
  • Osiris Therapeutics, Inc (United States)
  • Sigma-Aldrich Corporation (United States)
  • VWR Corporation (United States)
  • Biolife Solutions, Inc. (United States)
  • Lifeline Scientific, Inc. (United States)
  • Cesca Therapeutics, Inc. (United States)
  • BioCision, LLC (United States)
  • Core Dynamics, Ltd. (Israel)
  • Custom Biogenic Systems, Inc. (United States)
  • So-Low Environmental Equipment Co., Inc. (United States)
  • Princeton Cryotech, Inc. (United States)
Additional players considered in the study are as follows:
So-Low Environmental Equipment Co., Inc. (United States) , Princeton Cryotech, Inc. (United States)
Select User Access Type

Key Highlights of Report


Nov 2023 204 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Thermo Fisher Scientific, Inc. (United States), Osiris Therapeutics, Inc (United States), Sigma-Aldrich Corporation (United States), VWR Corporation (United States), Biolife Solutions, Inc. (United States), Lifeline Scientific, Inc. (United States), Cesca Therapeutics, Inc. (United States), BioCision, LLC (United States), Core Dynamics, Ltd. (Israel), Custom Biogenic Systems, Inc. (United States), So-Low Environmental Equipment Co., Inc. (United States) and Princeton Cryotech, Inc. (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Adoption in Conserving Cord Blood Stem Cells of Newborns " is seen as one of major influencing trends for Cryopreservation Media Market during projected period 2022-2028.
The Cryopreservation Media market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Cryopreservation Media Market Report?